OTCQX:MRVFF - Post by User
Post by
blackascanbeon Sep 13, 2011 2:17pm
355 Views
Post# 19037605
in the past week
in the past weeki listened to the two Nuvo presentations at the sept 8 and sept 13 health care conferences as well as the covidien investor presentation. From the Covidien presentation, Covidien is committed to Pennsaid. They want to expand their pain medication portfolio and they see pennsaid and exalgo as a foundation for that effort. John London said today that weekly scripts for pennsaid reached a record for the week ending Sept 2. Also wf10 looks like it could have multiple applications including for oncology, they are currently in the process of solidifying the intellectual property rights and expect to announce a commercial strategy by year end.